About this trial
Gestational diabetes mellitus (GDM) is associated with significant maternal and fetal complications. The standard diagnostic test for GDM is the 75-gram oral glucose tolerance test (OGTT). However, pregnant women who have undergone bariatric surgery may not tolerate OGTT due to dumping syndrome and gastrointestinal side effects. This creates diagnostic challenges in this specific population.
The aim of this prospective observational study is to evaluate whether routinely measured glycemic markers, including fasting blood glucose, postprandial blood glucose, HbA1c, and urinary glucose levels, can predict the development of gestational diabetes mellitus and related pregnancy complications in women with prior bariatric surgery.
Pregnant women aged 18-50 years with a history of bariatric surgery will be enrolled and followed throughout pregnancy. The predictive value of glycemic markers for GDM, macrosomia, and polyhydramnios will be analyzed using multivariable logistic regression models.
This study aims to provide alternative diagnostic approaches for GDM screening in pregnant women who are unable to tolerate OGTT and to contribute to improving maternal and perinatal outcomes in this growing patient population.
Eligibility criteria
Qualifiers
Pregnant women aged 18-50 years
Singleton pregnancy
History of bariatric surgery prior to pregnancy
Followed at Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Obstetrics and Gynecology
Disqualifiers
Age <18 years or >50 years
Multiple pregnancy
Presence of known chronic systemic disease (e.g., pregestational diabetes or endocrine disorders)
Incomplete or missing clinical data
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Burak Deniz Aydoğdu
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Sponsor institution